Natural Beauty Bio-Technology Limited

Natural Beauty Bio-Technology Limited

0.46
HKD
+0.02
(+3.37%)
930.98MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.22
0.25
0.25
0.24
0.2
0.18
0.22
0.21
0.24
0.17
0.17
0.18
0.27
- -
Basic EPS, GAAP
0.03
0.04
0.07
0.07
0.05
0.01
0.01
- -
0.02
-0.02
-0.01
-0.05
0.01
- -
Free Cash Flow per Basic Share
0.04
0.07
0.04
0.05
-0.01
0.01
-0.03
-0.02
- -
-0.02
-0.02
-0.03
-0.04
- -
Dividend per Share
0.01
0.04
0.07
0.1
0.08
0.05
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.39
0.39
0.37
0.33
0.33
0.28
0.28
0.31
0.33
0.3
0.29
0.22
0.24
0.21
Tangible Book Value per Share
0.37
0.37
0.33
0.29
0.29
0.23
0.26
0.28
0.31
0.29
0.27
0.22
0.24
0.21
Basic Weighted Avg Shares
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
Sales/Revenue/Turnover
439
506
507
475
400
370
438
411
488
336
336
354
539
- -
Operating Margin (%)
16.69
25.42
31.41
36.36
36.76
9.45
8.52
1.2
8.9
-7.24
-1.6
-14.79
4.8
- -
Depreciation Expense
40
39
34
24
22
26
31
37
35
34
27
32
39
- -
Net Income, GAAP
58
71
137
148
105
26
22
8
35
-30
-15
-104
11
- -
Effective Tax Rate (%)
29.61
38.52
19.7
24.37
28.18
32.94
40.79
13.64
27.23
- -
- -
- -
10.45
- -
Profit Margin (%)
13.26
14.13
26.99
31.23
26.37
7.11
5
1.89
7.23
-9.07
-4.5
-29.3
1.96
- -
Working Capital
487
505
466
403
376
222
202
196
212
114
60
101
35
-25
LT Debt
- -
- -
- -
- -
- -
- -
31
16
34
24
15
138
132
143
Total Equity
788
774
733
655
651
552
568
611
658
597
575
448
474
424
Return on Invested Capital (%)
7.43
10.94
18.32
21.05
15.07
4.19
3.77
1.39
4.87
- -
- -
- -
2.84
- -
Return on Capital (%)
7.56
9.15
18.16
21.39
16.15
4.37
3.87
1.41
4.97
- -
- -
- -
2.75
- -
Return on Common Equity (%)
7.58
9.15
18.16
21.39
16.15
4.37
3.91
1.32
5.56
-4.85
-2.58
-20.27
2.3
- -

Capital Structure

HKD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
79
187
282
LT Borrowings
128
117
127
LT Finance Leases
14
15
16
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2,002
2,002
2,002
Market Capitalization
1,101
981
931

Working Capital

HKD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
326
354
419
Cash, Cash Equivalents & STI
97
112
116
Accounts Receivable, Net
108
121
168
Inventories
92
95
107
Total Current Liabilities
224
319
444
Payables & Accruals
- -
- -
- -
ST Debt
79
187
282
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3.75%
-4.32%
5.9%
Free Cash Flow
-135.49%
-121.07%
52.41%
Net Income, GAAP
41.64%
118.64%
-110.21%
Sales/Revenue/Turnover
2.79%
9.06%
52.36%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
354
2025
- -
- -
539
2026
- -
- -
- -

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.05
2025
- -
- -
0.01
2026
- -
- -
- -

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Chi Chung Cheng
Full Time Employees
597
Sector
Consumer non-durables
Industry
Household/Personal care
Address
Lee Garden One Hong Kong Hong Kong
IPO Date
Mar 28, 2002
Business
Natural Beauty Bio-Technology Limited, an investment holding company founded in 1976 and headquartered in Causeway Bay, Hong Kong, manufactures and sells skin care, beauty and aroma-therapeutic products, health supplements, make-up products and beauty apparatus under the Natural Beauty brand; it also provides skin treatments, beauty and spa services including hydrotherapy, facial treatment, body care and skin care analysis, medical cosmetology, skin care consulting and beauty training services, as well as wholesale of skin care and beauty products. The company operates principally in Mainland China, Taiwan and internationally, with a network of over 2,000 outlets primarily through franchisees that contributed approximately 79% of revenue in recent years. Its major shareholder is Far Eastern Silo & Shipping (Panama) S.A., and it maintains ongoing procurement and consignment agreements with related entities such as Eastern Home and Eastern Global for health supplements and skin care products. In the first half of 2025, the company reported interim profit surging 136% to HK$11 million on turnover up nearly 70% to over HK$260 million, driven by Mainland China operations which grew 101% year-on-year, franchise channel turnover up 115% with 237 new stores added (an 88% increase), self-owned channels up 112%, and health supplements up 110%. It launched the White Moonlight product series through a strategic partnership with Spain's INDIBA, integrating their AI technology devices with proprietary formulations to create a market bestseller. The company is proposing adoption of a 2025 share option scheme and amendment to its share award scheme II at an extraordinary general meeting on 19 December 2025 to incentivize employees, directors, related entity participants and service providers including top-performing franchisees and distributors.